| abstract |
Stable, aqueous pharmaceutical compositions of human growth factor nerve (NGF) in aqueous isotonic solutions, buffered to maintain pH between 4.5 and 6.0 and optionally contain carriers such as human2. with rum albumin. Thus, NGF formulations suitable for lyophilization and subsequent reconstitution are described in which rhNGF is mixed with sugars, optionally with HSA and buffer. Means can be used to treat Alzheimer's disease and other neuronal dysfunctions. |